Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02815397
Title DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rush University Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Medical Center Chicago Illinois 60612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field